Transaction · 0002048497-26-000012

Hopman Mark

Hopman Mark, CCO, reported an open-market or private sale at Beta Bionics, Inc. involving 5327.000000 shares for an estimated $101815.48. Reported holdings after the transaction were 124027.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCCO
BBNXBeta Bionics, Inc.
Filing timeSep 03
Trade dateSep 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$19.92
Pre-filing
1mo ago -33.0%1w ago -2.9%1d ago -4.3%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

BBNX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
BBNX since 2026-09-03Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002048497-26-000012
Common Stock
Transaction date
Sep 02, 2026
Filed Sep 03, 2026, 10:15 PM · 1d delay
Shares
5.32k sh
$1.91k per share
Estimated value
-$10.1M
Computed from shares × price
Holdings after
124k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Commercial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

  2. F2

    The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of…

Original filing · 0002048497-26-000012
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

BBNX